Vimarsana
Biggest News Aggregation in the World

Integrated Pharma Services News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Integrated Pharma Services. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Integrated Pharma Services Today - Breaking & Trending Today

Multi-Faceted Maryland - Vimarsana News

Multi-Faceted Maryland

Initiatives in Maryland for education, environment, and global reach are driving growth across this Mid-Atlantic state.

In Md., medical manufacturing grants a short-term boost but not a long-term gain - Vimarsana News

In Md., medical manufacturing grants a short-term boost but not a long-term gain

Grants to Maryland companies manufacturing medical supplies early in the COVID-19 pandemic were successful in the short-term, Department of Commerce data shows, but have made little impact on the state’s manufacturing capability since then. The state invested over $3.1 million in grants of as much as $100,000 to companies that pivoted to manufacture items ...

Tests show Micrillon yarns deactivate human coronavirus - Vimarsana News

Tests show Micrillon yarns deactivate human coronavirus

Tests show Micrillon yarns deactivate human coronavirus Results show significant potential for various applications, including the use of Micrillon yarns in PPE. 20th January 2021 UMF Corporation today announced that testing from award-winning contract research organization Integrated Pharma Services, confirms that it’s Micrillon sheath and core fibre demonstrates significant antiviral properties against Human Coronavirus, which causes COVID-19, and Human Influenza A H1N1 virus in just minutes. The Micrillon sheath and core fibre, spun into a yarn and knitted into a material, also demonstra...

UMF Corporation Announces Laboratory Results Showing its Micrillon® Yarns Inactivate Human Coronavirus and Human Influenza A H1N1, and Destroy MRSA and E. coli - Vimarsana News

UMF Corporation Announces Laboratory Results Showing its Micrillon® Yarns Inactivate Human Coronavirus and Human Influenza A H1N1, and Destroy MRSA and E. coli

Share this article Share this article SKOKIE, Ill., Jan. 19, 2021 /PRNewswire/ -- UMF Corporation today announced that testing from award-winning contract research organization Integrated Pharma Services confirms that UMF's Micrillon® sheath and core fiber demonstrates significant antiviral properties against Human Coronavirus, which causes COVID-19, and Human Influenza A H1N1 virus in just minutes. The Micrillon sheath and core fiber, spun into a yarn and knitted into a material, also demonstrates significant antibacterial efficacy (100% kill) against S taphylococcus aureus (MRSA) and ...